Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study. [PDF]
Gotlib J +34 more
europepmc +1 more source
Multiphasic anaphylaxis in the emergency and intensive care setting. [PDF]
Schneider MA, de Groot H, Geerts JW.
europepmc +1 more source
Avapritinib in the treatment of systemic mastocytosis with associated acute myeloid leukemia after poor graft function following allogeneic hematopoietic stem cell transplantation: a case study and review of the literature. [PDF]
Mi R +6 more
europepmc +1 more source
Near-Fatal Mastocytosis Mimicking as Malignant Vasovagal Syncope. [PDF]
Estublier B +7 more
europepmc +1 more source
A successful treatment of urticaria pigmentosa with omalizumab in a pediatric patient: a case report. [PDF]
Alhajri A +6 more
europepmc +1 more source
Diagnostics and monitoring in Hymenoptera venom allergy: current and future perspectives. [PDF]
Wilińska W, Starosz A, Grubczak K.
europepmc +1 more source
Clinical remission in allergy and clinical immunology practice: State of the art and World Allergy Organization (WAO) call to action. [PDF]
Morais-Almeida M +28 more
europepmc +1 more source
Fatal reactions to alpha-gal might be due to comorbid mast cell diseases. [PDF]
Moraczewski J, Stone CA.
europepmc +1 more source
Avapritinib and corticosteroids in advanced systemic mastocytosis with tumoral CMML and associated thrombocytopenia. [PDF]
Abakarim O +7 more
europepmc +1 more source

